Samer Nasser

Statistics

Publications

Citations

637

H-Index

Active since

2003

Affiliations

Charité - Universitätsmedizin Berlin(Current)

Christian-Albrechts-Universität zu Kiel

Ludwig-Maximilians-Universität München

University of Cologne

University Hospital Bonn

Samer Nasser is an author at Charité - Universitätsmedizin Berlin specializing in interferon-based therapy, hepatitis pharmacotherapy, and viral hepatitis treatment.

Publications per year

2003–2010

Publications

Extended Treatment Duration for Hepatitis C Virus Type 1: Comparing 48 Versus 72 Weeks of Peginterferon-Alfa-2a Plus Ribavirin

Thomas Berg, Michael Wagner, Samer Nasser et al. · Gastroenterology · 2006 · 519 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Triple Therapy With Amantadine in Treatment–Naive Patients With Chronic Hepatitis C: A Placebo–Controlled Trial

Thomas Berg, Bernd Kronenberger, Holger Hinrichsen et al. · Hepatology · 2003 · 65 citations · Full text

Pharmacy, Infectious Diseases, Clinical Pharmacology +15

Revascularization of traumatic renal artery dissection by endoluminal stenting: Three cases

P. Chabrot, L. Cassagnes, A. Alfidja et al. · Acta Radiologica · 2010 · 19 citations

Medicine, Nephrology, Surgery +17

Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-α and ribavirin: results from a randomized, placebo-controlled, double-blind trial

Bernd Kronenberger, Thomas Berg, Eva Herrmann et al. · European Journal of Gastroenterology & Hepatology · 2007 · 18 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Rhabdomyolysis associated with phentermine

Kelly E. Steidl, William Darko, Luke A. Probst et al. · American Journal of Health-System Pharmacy · 2010 · 16 citations

Nursing, Pharmacology, Pharmacotherapy +13

1–5 of 5